000 01435 a2200385 4500
005 20250518051140.0
264 0 _c20190822
008 201908s 0 0 eng d
022 _a1432-0851
024 7 _a10.1007/s00262-019-02364-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFortis, Sotirios P
245 0 0 _a4th Symposium on Advances in Cancer Immunology and Immunotherapy, November 29-December 1, 2018, Athens, Greece.
_h[electronic resource]
260 _bCancer immunology, immunotherapy : CII
_c08 2019
300 _a1391-1400 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents, Immunological
_ximmunology
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_ximmunology
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aClinical Trials as Topic
650 0 4 _aCongresses as Topic
650 0 4 _aGreece
650 0 4 _aHumans
650 0 4 _aImmunity, Innate
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aTreatment Outcome
700 1 _aKotsakis, Athanasios
700 1 _aLe Tourneau, Christophe
700 1 _aTsitsilonis, Ourania E
700 1 _aGeorgoulias, Vassilis
700 1 _aBaxevanis, Constantin N
773 0 _tCancer immunology, immunotherapy : CII
_gvol. 68
_gno. 8
_gp. 1391-1400
856 4 0 _uhttps://doi.org/10.1007/s00262-019-02364-2
_zAvailable from publisher's website
999 _c29904792
_d29904792